Hormone Receptor Testing & Personalized Cancer Medicine

Ajouter une nouvelle offre d'emploi Health

2026-06-18 12:23:33 -

Hormone Receptor Testing is a cornerstone of Personalized Cancer Medicine in breast cancer, enabling the selection of endocrine therapy for patients who are most likely to benefit. The global breast cancer market is projected to reach USD 12,880.85 million by 2035, driven by advances in personalized medicine and targeted therapies [URL]. For oncologists, pathologists, and...

0 Commentaires 0 Parts 78 Vue 0 Aperçu